Research internship report at Bluepharma Indústria Farmacêutica, S.A.

Detalhes bibliográficos
Autor(a) principal: Fernandes, Mariana Amaral
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/32117
Resumo: This report intends to describe the work developed during the internship at Bluepharma Indústria Farmacêutica, S.A., in Research and Innovation sector. The first aim of this internship was to complete a review about long-acting injectables (LAI) and their characterization, as well as in vitro release. Thus, an overview of LAIs, their characterization methods, including in vitro release methods, possible membranes or barriers, and biorelevant characteristics is presented. The second aim was to support the development of the most appropriate methodology for assessing the release profile of LAI technology with an extended release of at least 96 hours develop internally. So, a description of developed activities is stated, presenting the rationale behind the choice of the method, the analytical development of the HPLC-PDA method to quantification of the drug substance (DS) and its pre-validation according to the authorities guidelines. Although the analytical method is already studied, the formulation development was not completed until the end of the internship, whereby the analytical method as well as the chosen method (including apparatus, barrier, ect.) to assess the in vitro release could need optimization with the final drug product.
id RCAP_06f5b520d5a53b714ee98de0d7038e0e
oai_identifier_str oai:ria.ua.pt:10773/32117
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Research internship report at Bluepharma Indústria Farmacêutica, S.A.BiorelevanceLong-Acting Injectables (LAI)Extended-releaseCharacterization techniquesIn vitro releaseThis report intends to describe the work developed during the internship at Bluepharma Indústria Farmacêutica, S.A., in Research and Innovation sector. The first aim of this internship was to complete a review about long-acting injectables (LAI) and their characterization, as well as in vitro release. Thus, an overview of LAIs, their characterization methods, including in vitro release methods, possible membranes or barriers, and biorelevant characteristics is presented. The second aim was to support the development of the most appropriate methodology for assessing the release profile of LAI technology with an extended release of at least 96 hours develop internally. So, a description of developed activities is stated, presenting the rationale behind the choice of the method, the analytical development of the HPLC-PDA method to quantification of the drug substance (DS) and its pre-validation according to the authorities guidelines. Although the analytical method is already studied, the formulation development was not completed until the end of the internship, whereby the analytical method as well as the chosen method (including apparatus, barrier, ect.) to assess the in vitro release could need optimization with the final drug product.Este relatório pretende descrever o trabalho desenvolvido durante o estágio na Bluepharma Indústria Farmacêutica, S.A., no setor de Investigação e Inovação. O primeiro objetivo deste estágio consistia em realizar uma revisão da literatura sobre os injetáveis de ação prolongada (LAI) e a sua caracterização, incluindo testes de liberação in vitro. Assim, é apresentada uma visão geral sobre os LAI, os seus métodos de caracterização, incluindo métodos de libertação in vitro, possíveis membranas ou barreiras usadas e características biorelevantes aplicáveis ao estudo. O segundo objetivo envolvia o apoio ao desenvolvimento de uma metodologia adequada para avaliar o perfil de libertação de uma tecnologia LAI com libertação prolongada de pelo menos 96 horas desenvolvida internamente. Assim, na segunda parte do relatório é apresentada uma descrição das atividades desenvolvidas, expondo o racional para a escolha do método, o desenvolvimento analítico do método HPLC-PDA para quantificação do princípio ativo (DS) e sua pré-validação de acordo com as diretrizes das autoridades. Embora o método analítico já tenha sido estudado, o desenvolvimento da formulação não tinha sido concluído até o término do estágio, pelo que o método analítico, bem como o método escolhido para determinação do perfil de libertação in vitro (incluindo apparatus, barreira, etc.) podem necessitar de otimização com o produto final.2021-09-15T08:42:54Z2021-07-29T00:00:00Z2021-07-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/32117engFernandes, Mariana Amaralinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T12:02:10Zoai:ria.ua.pt:10773/32117Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:03:57.742998Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Research internship report at Bluepharma Indústria Farmacêutica, S.A.
title Research internship report at Bluepharma Indústria Farmacêutica, S.A.
spellingShingle Research internship report at Bluepharma Indústria Farmacêutica, S.A.
Fernandes, Mariana Amaral
Biorelevance
Long-Acting Injectables (LAI)
Extended-release
Characterization techniques
In vitro release
title_short Research internship report at Bluepharma Indústria Farmacêutica, S.A.
title_full Research internship report at Bluepharma Indústria Farmacêutica, S.A.
title_fullStr Research internship report at Bluepharma Indústria Farmacêutica, S.A.
title_full_unstemmed Research internship report at Bluepharma Indústria Farmacêutica, S.A.
title_sort Research internship report at Bluepharma Indústria Farmacêutica, S.A.
author Fernandes, Mariana Amaral
author_facet Fernandes, Mariana Amaral
author_role author
dc.contributor.author.fl_str_mv Fernandes, Mariana Amaral
dc.subject.por.fl_str_mv Biorelevance
Long-Acting Injectables (LAI)
Extended-release
Characterization techniques
In vitro release
topic Biorelevance
Long-Acting Injectables (LAI)
Extended-release
Characterization techniques
In vitro release
description This report intends to describe the work developed during the internship at Bluepharma Indústria Farmacêutica, S.A., in Research and Innovation sector. The first aim of this internship was to complete a review about long-acting injectables (LAI) and their characterization, as well as in vitro release. Thus, an overview of LAIs, their characterization methods, including in vitro release methods, possible membranes or barriers, and biorelevant characteristics is presented. The second aim was to support the development of the most appropriate methodology for assessing the release profile of LAI technology with an extended release of at least 96 hours develop internally. So, a description of developed activities is stated, presenting the rationale behind the choice of the method, the analytical development of the HPLC-PDA method to quantification of the drug substance (DS) and its pre-validation according to the authorities guidelines. Although the analytical method is already studied, the formulation development was not completed until the end of the internship, whereby the analytical method as well as the chosen method (including apparatus, barrier, ect.) to assess the in vitro release could need optimization with the final drug product.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-15T08:42:54Z
2021-07-29T00:00:00Z
2021-07-29
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/32117
url http://hdl.handle.net/10773/32117
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137694944591872